| Literature DB >> 34853335 |
Ishita Choudhary1, Thao Vo1, Kshitiz Paudel1, Xue Wen2, Richa Gupta3, Mehmet Kesimer3, Sonika Patial1, Yogesh Saini4.
Abstract
Lung epithelial lining fluid (ELF) harbors a variety of proteins that influence homeostatic and stress responses in the airspaces. Exosomes, nano-sized extracellular vesicles, contain many proteins that vary in abundance and composition based on the prevailing conditions. Ozone causes inflammatory responses in the airspaces of experimental animals and humans. However, the exosomal protein signatures contained within the ELF from ozone-exposed lung airspaces remain poorly characterized. To explore this, we hypothesized that ozone triggers the release of exosome-bound inflammatory proteins from various cells that reflect mucoobstructive lung disease. Accordingly, we repetitively exposed adult male and female C57BL/6 mice to HEPA-filtered air (air) or 0.8 ppm ozone (4 h per day) for 14 days (five consecutive days of exposure, 2 days of rest, five consecutive days of exposure, 2 days of rest, four consecutive days of exposure). Exosome-bound proteomic signatures, as well as the levels of soluble inflammatory mediators in the bronchoalveolar lavage fluid (BALF), were determined 12-16 h after the last exposure. Principal component analyses of the exosome-bound proteome revealed a clear distinction between air-exposed and ozone-exposed mice, as well as between ozone-exposed males and ozone-exposed females. In addition to 575 proteins that were enriched in both sexes upon ozone exposure, 243 and 326 proteins were enriched uniquely in ozone-exposed males and females, respectively. Ingenuity pathway analyses on enriched proteins between ozone- and air-exposed mice revealed enrichment of pro-inflammatory pathways. More specifically, macrophage activation-related proteins were enriched in exosomes from ozone-exposed mice. Cytokine analyses on the BALF revealed elevated levels of G-CSF, KC, IP-10, IL-6, and IL-5 in ozone-exposed mice. Finally, the histopathological assessment revealed significantly enhanced intracellular localization of mucoinflammatory proteins including MUC5B and FIZZ1 in ozone-exposed mice in a cell-specific manner indicating the cellular sources of the proteins that are ferried in the exosomes upon ozone-induced lung injury. Collectively, this study identified exosomal, secretory, and cell-specific proteins and biological pathways following repetitive exposure of mice to ozone.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34853335 PMCID: PMC8636509 DOI: 10.1038/s41598-021-02256-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1(A) Ozone exposure causes exaggerated lung injury and inflammatory mediators in ozone-exposed mice. (A) Protein concentration (µg/ml) in the cell-free BALF from the air- and ozone-exposed males and females. Significant main effect was detected (Kruskal Wallis Statistic = 40.34; df = 3; p < 0.0001). Concentration (pg/ml) of G-CSF (B), CXCL1 (KC) (C), IP-10 (D), IL-6 (E), and IL-5 (F), in the cell-free BALF from air- and ozone-exposed males and females. The G-CSF and IL-6 concentrations for air-exposed groups in Panels B and E, respectively, were below detection limit. The values for such samples were obtained by subtracting 0.01 from lowest detection limit. Significant main effect was detected for G-CSF, KC, IP-10, IL-6, and IL-5 (Kruskal Wallis Statistic = 35.67 for IL-6, 41.72 for G-CSF, 27.64 for IL-5, 35.97 for IP-10, and 41.15 for KC; df = 3 for all; p < 0.0001 for all). (G) Double-stranded DNA (dsDNA) concentration (ng/ml) in the cell-free BALF from the air- and ozone-exposed males and females. Significant main effect was detected (Kruskal Wallis Statistic = 29.89; df = 3; p < 0.0001). Error bars represent Standard Deviation (SD). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 using Kruskal Wallis test followed by Dunn’s post hoc comparisons. (n = 13–14 per group). BALF, bronchoalveolar lavage fluid; G-CSF, Granulocyte colony-stimulating factor; CXCL1, Chemokine (C-X-C motif) ligand 1; KC, Keratinocytes-derived chemokine; IP-10, Interferon-gamma induced protein 10; IL-6, Interleukin 6; IL-5, Interleukin 5.
Figure 2Exosome harvest and analyses for exosome-specific protein signatures. (A) Flow diagram (created with www.biorender.com) delineating designated steps involved in BALF processing for proteomics data analyses. (B) Total protein yield (µg) in the exosomes harvested from the air- and ozone-exposed males and females. Significant main effect was detected (Kruskal Wallis Statistic = 8.744; df = 3; p = 0.006). Error bars represent Standard Deviation (SD). Analysis was done using Kruskal Wallis test followed by Dunn’s post hoc comparisons (n = 3 per group). (C) Venn diagram to show that 822 out of 1225 exosome-specific markers obtained from Vesiclepedia database were present in exosomes harvested in this study. (D) Table showing 29 exosome markers that were represented in the top 20% of the most abundant proteins.
Top 50 protein signatures enriched in air- and ozone-exposed mice.
| Exosomal proteins enriched in air-exposed mice | Exosomal proteins enriched in ozone-exposed mice | ||||||
|---|---|---|---|---|---|---|---|
| Protein | Description | Ranking in | Protein | Description | Ranking in | ||
| Air | Ozone | Ozone | Air | ||||
| ALB | Serum albumin | 1 | 1 | ALB | Serum albumin | 1 | 1 |
| SCGB1A1 | Uteroglobin | 2 | 3 | HIST1H4A | Histone H4 | 2 | |
| TF | Serotransferrin | 3 | 8 | SCGB1A1 | Uteroglobin | 3 | 2 |
| SFTPD | Pulmonary surfactant-associated protein D | 4 | 5 | HIST1H2B | Histone H2B | 4 | |
| TTR | Transthyretin | 5 | 12 | SFTPD | Pulmonary surfactant-associated protein D | 5 | 4 |
| SFTPA1 | Pulmonary surfactant-associated protein A | 6 | 9 | ACTB | Actin, cytoplasmic 1 | 6 | 9 |
| CYP2F2 | Cytochrome P450 2F2 | 7 | 36 | HIST1H2A | Histone H2A | 7 | |
| CES1D | Carboxylesterase 1D | 8 | 29 | TF | Serotransferrin | 8 | 3 |
| ACTB | Actin, cytoplasmic 1 | 9 | 6 | SFTPA1 | Pulmonary surfactant-associated protein A | 9 | 6 |
| PRDX6 | Peroxiredoxin-6 | 10 | 11 | H3F3A | Histone H3.2;Histone H3 | 10 | |
| PRSS1 | Cationic Trypsinogen | 11 | 26 | PRDX6 | Peroxiredoxin-6 | 11 | 10 |
| AHSG | Alpha-2-HS-glycoprotein | 12 | 16 | TTR | Transthyretin | 12 | 5 |
| HP | Haptoglobin | 13 | 20 | TRY4;TRY5 | Trypsin 4; 5 | 13 | |
| HPX | Hemopexin | 14 | 24 | GPRC5A | Retinoic acid-induced protein 3 | 14 | 29 |
| LYZ2 | Lysozyme C-2 | 15 | BPIFB1 | BPI fold-containing family B member 1 | 15 | 20 | |
| ALDH1A1 | Retinal dehydrogenase 1 | 16 | 22 | AHSG | Alpha-2-HS-glycoprotein | 16 | 12 |
| CHIL3 | Chitinase-like protein 3 | 17 | ANXA5 | Annexin A5 | 17 | 36 | |
| CYB5A | Cytochrome b5 | 18 | RPS27A | Ubiquitin-40S ribosomal protein S27a | 18 | 40 | |
| SERPINA1E | Alpha-1-antitrypsin 1–5 | 19 | 34 | APOA4 | Apolipoprotein A-IV | 19 | 27 |
| BPIFB1 | BPI fold-containing family B member 1 | 20 | 15 | HP | Haptoglobin | 20 | 13 |
| HBA | Hemoglobin subunit alpha | 21 | 39 | HIST1H1C | Histone H1.2 | 21 | |
| SOD1 | Superoxide dismutase [Cu–Zn] | 22 | 41 | ALDH1A1 | Retinal dehydrogenase 1 | 22 | 16 |
| CHI3L1 | Chitinase-3-like protein 1 | 23 | SEC14L3 | SEC14 like Lipid Binding 3 | 23 | 32 | |
| SELENBP1;2 | Selenium-binding protein 1; 2 | 24 | 27 | HPX | Hemopexin | 24 | 14 |
| SERPINA1D | Alpha-1-antitrypsin 1–4 | 25 | 25 | SERPINA1D | Alpha-1-antitrypsin 1–4 | 25 | 25 |
| CES1C | Carboxylesterase 1C | 26 | 50 | PRSS1 | Cationic Trypsinogen | 26 | 11 |
| APOA4 | Apolipoprotein A-IV | 27 | 19 | SELENBP1;2 | Selenium-binding protein 1; 2 | 27 | 24 |
| HBB-BS | Hemoglobin subunit beta-1 | 28 | GSN | Gelsolin | 28 | 37 | |
| GPRC5A | Retinoic acid-induced protein 3 | 29 | 14 | CES1D | Carboxylesterase 1D | 29 | 8 |
| PON1 | Serum paraoxonase/arylesterase 1 | 30 | ANXA1 | Annexin A1 | 30 | ||
| SFTPB | Pulmonary surfactant-associated protein B | 31 | MSN | Moesin | 31 | 39 | |
| SEC14L3 | SEC14 like Lipid Binding 3 | 32 | 23 | CALM1 | Calmodulin 1 | 32 | 48 |
| METTL7A1 | Methyltransferase-like protein 7A | 33 | ANXA2 | Annexin A2;Annexin | 33 | ||
| POR | NADPH–cytochrome P450 reductase | 34 | SERPINA1E | Alpha-1-antitrypsin 1–5 | 34 | 19 | |
| SERPINA1B | Alpha-1-antitrypsin 1–2 | 35 | CD36 | Platelet glycoprotein 4 | 35 | 44 | |
| ANXA5 | Annexin A5 | 36 | 17 | CYP2F2 | Cytochrome P450 2F2 | 36 | 7 |
| GSN | Gelsolin | 37 | 28 | ANXA3 | Annexin A3 | 37 | |
| CBR2 | Carbonyl reductase [NADPH] 2 | 38 | 40 | SDCBP | Syntenin-1 | 38 | |
| MSN | Moesin | 39 | 31 | HBA | Hemoglobin subunit alpha | 39 | 21 |
| RPS27A | Ubiquitin-40S ribosomal protein S27a | 40 | 18 | CBR2 | Carbonyl reductase [NADPH] 2 | 40 | 38 |
| FTL1;FTL2 | Ferritin | 41 | SOD1 | Superoxide dismutase [Cu–Zn] | 41 | 22 | |
| MGST1 | Microsomal glutathione S-transferase 1 | 42 | APOA1 | Apolipoprotein A-I | 42 | ||
| FTH1 | Ferritin heavy chain | 43 | AQP5 | Aquaporin-5 | 43 | ||
| CD36 | Platelet glycoprotein 4 | 44 | 35 | S100A11 | Protein S100-A11 | 44 | |
| IGHG2B | Ig gamma-2B chain C region | 45 | S100A6 | Protein S100-A6 | 45 | ||
| P4HB | Protein disulfide-isomerase | 46 | RETNLA | Resistin-like alpha | 46 | ||
| TUBB4B; 4A | Tubulin beta-4B chain; 4A chain | 47 | 47 | TUBB4B;4A | Tubulin beta-4B chain; 4A chain | 47 | 47 |
| CALM1 | Calmodulin 1 | 48 | 32 | HSPA8 | Heat shock cognate 71 kDa protein | 48 | |
| SERPINC1 | Antithrombin-III | 49 | RHOA | Transforming protein RhoA | 49 | ||
| C5 | Complement C5 | 50 | CES1C | Carboxylesterase 1C | 50 | 26 | |
Ranking column on the right of Air (or Ozone) column indicates the ranking of the protein in the ozone (or air) group. Bold text indicate that the corresponding protein is not present in top 50 in the respective exposure group.
Figure 3Ozone exposure results in alterations in the airspace exosome-bound proteome. (A) Two-dimensional principal component (PC) analysis plot using PC1 and PC2 on differentially enriched proteins (after normalization) in exosomes from the air- and ozone-exposed mice. (B–F) Volcano plots depicting differentially abundant proteins (enriched and low abundance) in four different comparisons that were identified using cutoff criteria [Log2 Fold change > 2, -Log10 (FDR adjusted p-values < 0.05)]. (B) air-exposed females versus air-exposed males, (C) ozone-exposed females versus ozone-exposed males, (D) ozone-exposed males versus air-exposed males, (E) ozone-exposed females versus air-exposed females. (n = 3 per sex per treatment) and (F) ozone-exposed mice (both sexes) versus air-exposed mice (both sexes). Venn diagram (G) depicting common and unique differentially enriched proteins (enriched and low abundance) in ozone-exposed males versus air-exposed males and ozone-exposed females versus air-exposed females. Tabular (H) summary of the Venn diagram.
Top differentially enriched protein signatures between (A) air-exposed females and air-exposed males, (B) ozone-exposed females and ozone-exposed males.
| Protein | Description | FC | Adj. |
|---|---|---|---|
| (A) Air-exposed females vs air-exposed males | |||
| SIPA1L3 | Signal-induced proliferation-associated 1-like protein 3 | 112.60 | 4.0E−07 |
| CDCP1 | CUB domain-containing protein 1 | 56.22 | 0.0306 |
| HECTD1 | E3 ubiquitin-protein ligase HECTD1 | 11.09 | 0.0306 |
| CGN | Cingulin | 8.07 | 0.0137 |
| NA | Ig kappa chain V–III region PC 3741/TEPC 111; Ig kappa chain V–III region TEPC 124 | 3.92 | 0.0361 |
| PTPN23 | Tyrosine-protein phosphatase non-receptor type 23 | − 424.61 | 0.0000 |
| MUP20 | Major urinary protein 20 | − 40.28 | 0.0001 |
| MUP4, 6, 8, 9, 19 | Major urinary protein 4, 6, 8, 9, 19 | − 29.90 | 0.0001 |
| CLIP1 | CAP-Gly domain-containing linker protein 1 | − 9.45 | 0.0383 |
| WNK1 | Serine/threonine-protein kinase WNK1 | − 7.51 | 0.0306 |
| MUP10; MUP1 | Major urinary protein 10 | − 4.84 | 0.0306 |
| C8G | Complement component C8 gamma chain | − 4.34 | 0.0511 |
| CFL2 | Cofilin-2 | − 4.07 | 0.0383 |
| SERPINA1E | Alpha-1-antitrypsin 1–5 | − 3.99 | 0.0306 |
| CDK16, 17, 18 | Cyclin-dependent kinase 16, 17, 18 | − 3.06 | 0.0383 |
| (B) Ozone-exposed females vs ozone-exposed males | |||
| CD5L | CD5 antigen-like | 8.75 | 0.0471 |
| VAMP5 | Vesicle-associated membrane protein 5 | 8.51 | 0.0417 |
| MSLN | Mesothelin; Megakaryocyte-potentiating factor; Mesothelin, cleaved form | 4.72 | 0.0417 |
| NA | Ig kappa chain V-III region PC 3741/TEPC 111; Ig kappa chain V-III region TEPC 124 | 3.89 | 0.0471 |
| LTF | Lactotransferrin | 3.56 | 0.0482 |
| H3F3C; H3F3A | Histone H3.3C;Histone H3.3;Histone H3 | − 73.52 | 0.0021 |
| MUP4; MUP9; MUP6;MUP8; MUP19 | Major urinary protein 6; Major urinary proteins 11 and 8 | − 29.65 | 0.0002 |
| MUP20 | Major urinary protein 20 | − 14.52 | 0.0046 |
| CFAP20 | Cilia- and flagella-associated protein 20 | − 12.13 | 0.0417 |
| PRKAR2B | cAMP-dependent protein kinase type II-beta regulatory subunit | − 4.66 | 0.0404 |
| AKAP2; PAKAP | A-kinase anchor protein 2 | − 3.71 | 0.0533 |
Top 50 protein signatures that were enriched in ozone-exposed mice versus air-exposed mice.
| Common in both sexes | Unique to males | Unique to females | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Protein | FC (Males) | Adj. | FC (Females) | Adj. | Protein | FC | Adj. | Protein | FC | Adj. |
| H1F0 | 366.00 | 0.0021 | 87.75 | 0.0061 | CDCP1 | 68.53 | 0.0012 | PTPN23 | 185.25 | 9.81E−06 |
| EPHA2 | 235.79 | 0.0004 | 89.75 | 0.0002 | SIPA1L3 | 29.20 | 0.0000 | CD151 | 59.59 | 0.0011 |
| H3F3A | 212.11 | 0.0000 | 4.77 | 0.0268 | ITGB6 | 21.11 | 0.0029 | CHMP2A | 30.31 | 0.0356 |
| HIST1H1B | 177.60 | 0.0000 | 43.06 | 0.0000 | STX4 | 18.14 | 0.0369 | APOD | 17.85 | 0.0030 |
| H2AFJ | 169.82 | 0.0000 | 117.94 | 0.0000 | PRPF8 | 13.15 | 0.0085 | DLG1 | 17.29 | 0.0197 |
| HIST1H1E | 104.76 | 0.0000 | 54.44 | 0.0001 | SNRPN | 13.01 | 0.0089 | SLC6A6 | 14.66 | 0.0115 |
| H2AFY | 103.52 | 0.0004 | 43.86 | 0.0009 | ARFGEF2 | 11.93 | 0.0059 | CKMT1 | 12.03 | 0.0057 |
| HIST1H2BR | 97.76 | 0.0000 | 92.89 | 0.0000 | HNRNPA1 | 11.68 | 0.0100 | PLA2G7 | 11.14 | 0.0038 |
| HIST1H3A | 95.05 | 0.0002 | 77.01 | 0.0006 | HSPA2 | 10.71 | 0.0036 | CHMP1B | 10.32 | 0.0094 |
| GP2 | 75.59 | 0.0012 | 58.81 | 0.0011 | TARDBP | 10.36 | 0.0181 | RPL35A | 10.28 | 0.0437 |
| HIST1H3B | 72.74 | 0.0000 | 127.66 | 0.0000 | PTGS2 | 10.11 | 0.0523 | PLAUR | 10.26 | 0.0099 |
| TNC | 68.46 | 0.0206 | 73.58 | 0.0069 | TRIM28 | 9.71 | 0.0037 | GLUD1 | 9.71 | 0.0127 |
| HIST1H1C | 65.82 | 0.0000 | 32.16 | 0.0001 | FBL | 9.16 | 0.0055 | MMP10 | 9.60 | 0.0214 |
| HIST1H4A | 62.93 | 0.0000 | 63.08 | 0.0000 | NCL | 8.12 | 0.0168 | MYO18A | 9.08 | 0.0038 |
| CKAP5 | 62.45 | 0.0012 | 41.38 | 0.0026 | LSR | 7.67 | 0.0044 | PIP5K1A | 8.93 | 0.0075 |
| HIST1H1D | 38.31 | 0.0000 | 16.95 | 0.0002 | RBBP7 | 7.58 | 0.0087 | RFTN1 | 8.78 | 0.0271 |
| SDCBP2 | 31.76 | 0.0028 | 51.70 | 0.0012 | COL4A3BP | 7.24 | 0.0029 | TSPO | 8.71 | 0.0164 |
| SNRPD1 | 25.93 | 0.0016 | 22.95 | 0.0014 | EIF2B5 | 7.18 | 0.0033 | CHMP5 | 7.08 | 0.0117 |
| EFTUD2 | 25.11 | 0.0007 | 25.33 | 0.0026 | MAP4 | 6.55 | 0.0047 | RALBP1 | 6.80 | 0.0408 |
| LLGL2 | 24.69 | 0.0000 | 19.85 | 0.0000 | LRRC8C | 5.94 | 0.0061 | DYNLT3 | 6.71 | 0.0338 |
| SLC23A2 | 21.64 | 0.0114 | 92.30 | 0.0008 | KEAP1 | 5.66 | 0.0314 | GM4788 | 6.51 | 0.0118 |
| SLC26A4 | 20.33 | 0.0004 | 8.83 | 0.0017 | PPFIBP2 | 5.63 | 0.0230 | CPNE1 | 6.50 | 0.0038 |
| MATN4 | 19.45 | 0.0056 | 8.35 | 0.0044 | STUB1 | 5.61 | 0.0122 | SH3GL1 | 6.46 | 0.0027 |
| EPB41L5 | 18.99 | 0.0004 | 11.32 | 0.0009 | NUMB | 5.46 | 0.0197 | PKP3 | 6.35 | 0.0094 |
| ITGAV | 17.78 | 0.0000 | 23.53 | 0.0000 | EPB41L4B | 5.44 | 0.0176 | CYBB | 6.29 | 0.0250 |
| KRT8 | 16.91 | 0.0001 | 9.81 | 0.0002 | APPL2 | 5.16 | 0.0287 | HADH | 6.29 | 0.0117 |
| HP1BP3 | 15.64 | 0.0029 | 11.95 | 0.0061 | ANXA8 | 5.12 | 0.0250 | COPS6 | 6.14 | 0.0085 |
| ITGA3 | 14.91 | 0.0001 | 17.14 | 0.0001 | SEPTIN_9 | 5.02 | 0.0114 | CAV2 | 6.11 | 0.0065 |
| ABHD4 | 14.24 | 0.0004 | 13.06 | 0.0002 | USP4 | 4.99 | 0.0121 | PAPSS2 | 6.09 | 0.0324 |
| COL6A2 | 13.71 | 0.0086 | 22.75 | 0.0029 | CGN | 4.92 | 0.0045 | ARFGEF1 | 5.96 | 0.0090 |
| CPNE8 | 13.68 | 0.0042 | 40.43 | 0.0006 | STEAP4 | 4.79 | 0.0147 | MLLT4 | 5.95 | 0.0079 |
| DDX5 | 13.59 | 0.0025 | 9.18 | 0.0036 | PRMT1 | 4.64 | 0.0089 | EXOC8 | 5.92 | 0.0065 |
| ITGA6 | 13.47 | 0.0021 | 11.89 | 0.0022 | GGA1 | 4.44 | 0.0118 | CAV1 | 5.81 | 0.0069 |
| RETNLA | 13.22 | 0.0029 | 15.46 | 0.0017 | RBBP4 | 4.38 | 0.0397 | CARS | 5.75 | 0.0532 |
| POSTN | 13.11 | 0.0080 | 21.36 | 0.0027 | HECTD1 | 4.31 | 0.0206 | SLC39A8 | 5.56 | 0.0085 |
| CTPS1 | 13.08 | 0.0001 | 16.39 | 0.0001 | DNM3 | 4.22 | 0.0291 | MSLN | 5.55 | 0.0013 |
| DHX9 | 13.04 | 0.0089 | 9.61 | 0.0120 | OSMR | 4.17 | 0.0533 | SORBS3 | 5.50 | 0.0197 |
| LMNA | 12.51 | 0.0003 | 14.49 | 0.0002 | EXOC4 | 4.15 | 0.0134 | COL4A2 | 5.46 | 0.0140 |
| NDNF | 12.00 | 0.0036 | 30.60 | 0.0020 | ARF5 | 4.15 | 0.0478 | Q8CEZ4 | 5.39 | 0.0205 |
| MACF1 | 11.87 | 0.0047 | 38.90 | 0.0005 | BRCC3 | 4.12 | 0.0279 | XPNPEP1 | 5.20 | 0.0291 |
| S100A16 | 11.60 | 0.0025 | 7.81 | 0.0042 | SUGT1 | 3.99 | 0.0280 | SNX4 | 5.17 | 0.0176 |
| CAPN7 | 10.88 | 0.0036 | 10.04 | 0.0030 | DNAJB4 | 3.85 | 0.0530 | RAB11FIP1 | 5.14 | 0.0095 |
| MUC5AC | 9.84 | 0.0156 | 17.73 | 0.0046 | RASGRF2 | 3.84 | 0.0208 | COPS8 | 5.08 | 0.0200 |
| FN1 | 9.58 | 0.0004 | 11.42 | 0.0002 | HERC4 | 3.81 | 0.0145 | VPS29 | 5.06 | 0.0441 |
| CHMP3 | 8.72 | 0.0036 | 11.83 | 0.0014 | RTKN | 3.78 | 0.0429 | CLIP1 | 4.94 | 0.0142 |
| PLXNA1 | 7.22 | 0.0010 | 20.10 | 0.0001 | ATG7 | 3.74 | 0.0419 | AGO2 | 4.80 | 0.0224 |
| COL6A3 | 7.04 | 0.0025 | 15.77 | 0.0003 | ANKRD13A | 3.64 | 0.0510 | EIF3E | 4.60 | 0.0114 |
| PTPRE | 6.92 | 0.0211 | 26.01 | 0.0017 | KLC2 | 3.63 | 0.0427 | GIPC1 | 4.53 | 0.0056 |
| BIRC6 | 6.53 | 0.0263 | 44.62 | 0.0008 | NEK9 | 3.56 | 0.0540 | MON2 | 4.47 | 0.0062 |
| ZDHHC5 | 5.96 | 0.0139 | 35.61 | 0.0009 | LPP | 3.48 | 0.0197 | CRYAB | 4.42 | 0.0026 |
Top 50 protein signatures that had significantly reduced abundance in ozone-exposed mice versus air-exposed mice.
| Common in both sexes | Unique to males | Unique to females | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Protein | FC (Males) | Adj. | FC (Females) | Adj. | Protein | FC | Adj. | Protein | FC | Adj. |
| MLF1 | − 109.96 | 0.0047 | − 1407.91 | 0.0018 | FABP1 | − 34.74 | 0.00454 | E030010N08RIK | − 41.09 | 0.0315 |
| GDPD1 | − 29.31 | 0.0049 | − 9.27 | 0.0250 | SLC22A18 | − 24.44 | 0.02592 | ATP13A1 | − 27.45 | 0.0113 |
| PMPCA | − 27.02 | 0.0014 | − 31.38 | 0.0025 | MAGT1 | − 19.03 | 0.01691 | ARHGEF7 | − 22.66 | 0.0071 |
| SLC27A2 | − 22.15 | 0.0029 | − 33.84 | 0.0011 | UFL1 | − 16.41 | 0.01862 | RNF213 | − 21.56 | 0.0063 |
| MERTK | − 20.86 | 0.0009 | − 6.88 | 0.0031 | AFP | − 15.18 | 0.03291 | DAD1 | − 19.74 | 0.0090 |
| EFHC1 | − 19.61 | 0.0037 | − 6.09 | 0.0261 | EMD | − 14.99 | 0.03432 | MIA3 | − 18.24 | 0.0161 |
| CLCC1 | − 18.19 | 0.0114 | − 15.72 | 0.0112 | DNAH9 | − 13.86 | 0.04258 | GPAA1 | − 17.64 | 0.0250 |
| CYP4A12 | − 16.69 | 0.0004 | − 23.68 | 0.0002 | IGHV1-47 | − 13.82 | 0.04187 | SLC27A1 | − 15.49 | 0.0054 |
| FGFR2 | − 15.19 | 0.0014 | − 49.82 | 0.0001 | FKBP8 | − 13.19 | 0.01126 | ITPR3 | − 15.14 | 0.0129 |
| GM2A | − 14.42 | 0.0018 | − 24.17 | 0.0005 | FAM3C | − 12.90 | 0.0085 | LMF1 | − 13.03 | 0.0107 |
| MTDH | − 14.01 | 0.0043 | − 11.51 | 0.0051 | CES2 | − 12.05 | 0.02864 | KDELC2 | − 12.61 | 0.0142 |
| CYP4F | − 13.44 | 0.0070 | − 17.41 | 0.0035 | RILPL1 | − 11.17 | 0.00304 | THEM6 | − 12.54 | 0.0105 |
| LSP1 | − 13.42 | 0.0001 | − 9.36 | 0.0001 | IGKV9-124 | − 9.75 | 0.0236 | EMC4 | − 11.74 | 0.0461 |
| IYD | − 12.55 | 0.0061 | − 9.62 | 0.0085 | HM13 | − 9.05 | 0.04311 | NBAS | − 11.52 | 0.0093 |
| BNIP1 | − 12.28 | 0.0037 | − 12.61 | 0.0017 | SPCS3 | − 9.04 | 0.02631 | BICD2 | − 11.34 | 0.0170 |
| MLF2 | − 12.01 | 0.0206 | − 11.17 | 0.0083 | PCCB | − 8.82 | 0.00454 | SPAG6 | − 10.84 | 0.0130 |
| TRP53I11 | − 11.40 | 0.0148 | − 11.64 | 0.0183 | ALG2 | − 7.90 | 0.04321 | LCLAT1 | − 10.56 | 0.0144 |
| CRELD2 | − 11.30 | 0.0165 | − 11.72 | 0.0081 | PCCA | − 7.87 | 0.00526 | CNPY2 | − 10.35 | 0.0075 |
| ILVBL | − 10.50 | 0.0357 | − 8.61 | 0.0465 | CELA1 | − 7.78 | 0.05386 | GNN | − 10.27 | 0.0036 |
| BC017158 | − 10.19 | 0.0147 | − 12.11 | 0.0088 | AK8 | − 7.50 | 0.05427 | SLC5A8 | − 10.26 | 0.0117 |
| CES1F | − 9.69 | 0.0113 | − 20.50 | 0.0026 | AMY2 | − 7.14 | 0.03483 | TNPO1 | − 10.19 | 0.0020 |
| ATP2A3 | − 9.18 | 0.0304 | − 16.25 | 0.0107 | DHRS7B | − 7.06 | 0.01876 | POFUT1 | − 9.844 | 0.0022 |
| THBS3 | − 9.11 | 0.0147 | − 8.92 | 0.0196 | VAMP5 | − 6.65 | 0.01059 | TMC4 | − 9.738 | 0.0027 |
| GAS6 | − 9.04 | 0.0008 | − 16.02 | 0.0002 | IGK-V19-17 | − 6.56 | 0.01323 | CNTFR | − 9.637 | 0.0029 |
| FMO1 | − 8.95 | 0.0157 | − 9.74 | 0.0107 | FAM213A | − 6.24 | 0.04285 | MCFD2 | − 9.555 | 0.0051 |
| TMX2 | − 8.79 | 0.0440 | − 7.70 | 0.0519 | TMED4 | − 6.17 | 0.02456 | RSPH4A | − 9.498 | 0.0141 |
| PIGS | − 8.78 | 0.0261 | − 7.32 | 0.0318 | IDH3B | − 6.00 | 0.02812 | KDSR | − 9.468 | 0.0137 |
| PGRMC1 | − 8.17 | 0.0021 | − 8.46 | 0.0014 | TMCO1 | − 5.96 | 0.03231 | SIGMAR1 | − 9.407 | 0.0061 |
| DPM1 | − 8.08 | 0.0141 | − 11.59 | 0.0057 | SFXN3 | − 5.91 | 0.01221 | ADPGK | − 9.22 | 0.0197 |
| CDIPT | − 7.93 | 0.0515 | − 11.64 | 0.0390 | ECI1 | − 5.79 | 0.0114 | GYS1 | − 9.11 | 0.0142 |
| LYZ2 | − 7.53 | 0.0007 | − 11.08 | 0.0002 | FAM160B1 | − 5.77 | 0.00454 | SUCLG2 | − 8.97 | 0.0279 |
| CHID1 | − 7.42 | 0.0147 | − 17.98 | 0.0039 | SGSH | − 5.77 | 0.0114 | IGKV10-94 | − 8.701 | 0.0111 |
| TMEM205 | − 7.21 | 0.0088 | − 8.57 | 0.0049 | ECHS1 | − 5.72 | 0.00802 | ABHD16A | − 8.674 | 0.0183 |
| HACD2 | − 7.02 | 0.0194 | − 8.42 | 0.0107 | BC017643 | − 5.63 | 0.02373 | DHCR7 | − 8.575 | 0.0146 |
| METTL7A1 | − 6.87 | 0.0053 | − 8.58 | 0.0027 | ICA1L | − 5.50 | 0.00577 | EPB4 | − 8.257 | 0.0036 |
| SLC27A4 | − 6.79 | 0.0292 | − 13.97 | 0.0069 | UBE2G2 | − 5.48 | 0.03 | FKBP2 | − 7.817 | 0.0137 |
| WFDC2 | − 6.74 | 0.0063 | − 13.51 | 0.0011 | GTPBP4 | − 5.13 | 0.03997 | BPIFB5 | − 7.806 | 0.0051 |
| STT3B | − 6.50 | 0.0405 | − 10.01 | 0.0158 | VKORC1 | − 4.90 | 0.05266 | IGHV1-5 | − 7.723 | 0.0183 |
| CES1E | − 6.45 | 0.0221 | − 15.26 | 0.0035 | LRRC37A | − 4.84 | 0.00822 | LMF2 | − 7.62 | 0.0253 |
| FGFR3;FGFR4 | − 6.44 | 0.0014 | − 11.70 | 0.0002 | PCDHGC3 | − 4.72 | 0.04258 | PRSS1 | − 7.527 | 0.0322 |
| UGT1A6 | − 6.38 | 0.0199 | − 9.30 | 0.0077 | IGHV1-9 | − 4.66 | 0.02679 | SDF2L1 | − 7.512 | 0.0247 |
| SPCS1 | − 6.34 | 0.0236 | − 15.49 | 0.0035 | ERGIC1 | − 4.61 | 0.05083 | TLR5 | − 7.421 | 0.0090 |
| ITPR1 | − 6.28 | 0.0530 | − 15.03 | 0.0170 | HADHA | − 4.55 | 0.03026 | ACADM | − 7.384 | 0.0283 |
| TMEM35 | − 6.10 | 0.0121 | − 17.46 | 0.0027 | FCN1 | − 4.36 | 0.04129 | PRKAR2B | − 7.375 | 0.0004 |
| TBL2 | − 5.75 | 0.0422 | − 10.60 | 0.0113 | DDAH2 | − 4.26 | 0.04271 | RPS25 | − 7.204 | 0.0102 |
| CYP2A | − 5.64 | 0.0014 | − 12.45 | 0.0001 | ORM1 | − 4.19 | 0.00759 | KTN1 | − 7.091 | 0.0241 |
| SLC4A1 | − 5.37 | 0.0527 | − 39.16 | 0.0025 | PTRH2 | − 4.14 | 0.02897 | IFITM1 | − 7.08 | 0.0033 |
| LYZ1 | − 4.78 | 0.0012 | − 13.95 | 0.0000 | CREG1 | − 4.09 | 0.00591 | TAPBP | − 7.005 | 0.0141 |
| ALG11 | − 4.57 | 0.0527 | − 15.11 | 0.0097 | SIRPA | − 3.99 | 0.01975 | SELT | − 6.912 | 0.0462 |
| CFAP20 | − 3.59 | 0.0230 | − 21.17 | 0.0005 | HDHD2 | − 3.98 | 0.02919 | LMAN2L | − 6.771 | 0.0102 |
Figure 4Heat map (A) for normalized protein abundance values (Z-scores) representing macrophage activation to classical (CAM, classically-activated macrophages) or alternative (AAM, alternatively-activated macrophages) responses. Higher and lower expressions of each protein are represented by red and blue colors, respectively. (B-G) Immunohistochemical analyses of lung sections for cell-specific expression of AAM-associated protein, i.e., RETNLA (FIZZ1). Red arrows point to the RETNLA-stained epithelial cells (B, air-exposed; C, ozone-exposed). Green arrows point to the macrophages that were positively stained for RETNLA (C, ozone-exposed). (D) Bar graph showing the proportion of epithelial cells in the small airways that were stained positive for RETNLA. Significant main effect was detected (Kruskal Wallis Statistic = 12.27; df = 3; p = 0.0004). Error bars represent Standard Deviation (SD). ***p < 0.001 using Kruskal Wallis test followed by Dunn’s post hoc comparisons (n = 3–5 per group). Green arrows point to the macrophages that remained unstained (E, air-exposed; G, ozone-exposed;) or those that were intensely stained for RETNLA (F, ozone-exposed).
Figure 5(A) Heat maps for normalized values (Z-scores) for proteins associated with mucoinflammatory lung diseases in mice and humans. Low-resolution heat map (Left) depicting expression patterns for the entire muco-inflammatory proteins (High resolution heatmap with protein names is presented as Supplemental Fig. 1). Heat map corresponding to protein signatures that were low abundance (Top) or enriched (Bottom) in exosomes from ozone-exposed mice was amplified for better resolution. (B–G) Immunohistochemical analyses of lung sections for expression of MUC5B in large airways (B and C) and small airways (E and F) from air-exposed (B and E) and ozone-exposed (C and F) mice. Significant main effect was detected for both large (Kruskal Wallis Statistic = 15.32; df = 3; p = 0.0016) and small (Kruskal Wallis Statistic = 15.17; df = 3; p = 0.0017) airways. Red arrows point to the MUC5B-stained epithelial cells (B, air-exposed; C and F, ozone-exposed). Bar graph showing the proportion of epithelial cells in the large (D) and small (G) airways that were stained positive for MUC5B. Error bars represent Standard Deviation (SD). **p < 0.01 using Kruskal Wallis test followed by Dunn’s post hoc comparisons (n = 5 per group).
Figure 6Biological pathway analyses on abundant proteins in BALF exosomes from air- and ozone-exposed mice. (A) Ingenuity pathway analysis (IPA) on most abundant (top 10%; 326 out of 3258 identified proteins, determined by Log2 VSN normalized iBAQ MS1 intensities) proteins in exosomes harvested from air-exposed mice. Pathways related to “molecular and cellular functions” and “Physiological system development and function” categories were interrogated for their enrichment. (B) Ingenuity pathway analysis (IPA) on most abundant (top 10%; 342 out of 3421 identified proteins, determined by Log2 VSN normalized iBAQ MS1 intensities) proteins in exosomes harvested from ozone-exposed mice. The asterisk represents pathways that were uniquely enriched in exosomes harvested from ozone-exposed mice.
Figure 7Comparative analysis of proteins in BALF exosomes from ozone- vs air-exposed mice reveal enrichment of inflammation/injury associated pathways. 1255 differentially expressed proteins (Total,1255; enriched, 568; low abundance, 687) were subjected to Ingenuity pathway analysis (IPA). Ingenuity pathway analysis (IPA) for the enrichment of (A) disease/functional pathways and (B) canonical pathways/biological networks altered in the exosomes from ozone-exposed mice. (C) IPA was performed to compare differentially expressed signatures in ozone-exposed males (versus air-exposed males; 380, enriched; 438, low abundance) and ozone-exposed females (versus air-exposed females; 427, enriched; 474, low abundance). Z-scores were used to plot heat maps. Only selected pathways are presented in this figure panel. A detailed heat map with all the differentially enriched pathways is included in Supplemental Fig. 2.
Comparative analyses of enriched protein signatures from ozone-exposed mice and transcriptome from three lung compartments.
| Gene signatures upregulated in Airways, Parenchyma, or Alveolar macrophages (FC > 1; adj | Number of enriched exosomal proteins (ozone vs air) (FC > 2; adj | Selected protein signatures |
|---|---|---|
Airways Parenchyma Alveolar macrophages | 180 | EPHA2, ITGA3, RETNLA, SLC26A4, MUC5AC, S100A16, SFTPC, F3, ITGB4, TSPAN8, FBL, ADAM10, AGER, CLCA1, S100A14, TGM2, CLEC7A, FGG, MUC4, TFRC, TSPO, LRP2, ANXA4, ANXA1, CLDN18, ADAM9, LDLR |
| Airways | 47 | ITGA6, ITGB1, ATP2B1, CKAP5, HGS, DNAJB4, |
| Parenchyma | 38 | CD151, ABCA3, ATP9A, FGA, APOC1, TLR2, TGFBR2, HIST1H1E |
| Alveolar macrophages | 59 | S100A9, TIMP3, PLA2G7, CD81, ANXA11, MACF1, TMEM2, H2-AB1, CAV1, PTGFRN, BMPR1A |
Airways Parenchyma | 66 | LMNA, H1F0, SAA1, TGM1, LGALS3, LGL2, HIST1H3B, APOD, LTF, A2M, IL1RN, S100A10, S100A11, EPCAM, SLC44A2 |
Airways Alveolar macrophages | 44 | TOP1, TSPAN2, TSPAN15, TNC, FCGR2B, CEACAM1, TOLLIP, CPNE8, ECM1, FLNB, CAPN7 |
Parenchyma Alveolar macrophages | 63 | ITGAV, COL6A1-3, TNC, SLC23A2, ITGF3, ITGA9, MMP3, COL4A2, KEAP1, C1QC, COL12A1, SLC16A1 |
| None | 71 | POSTN, NGP, HIST1G2BR, ARHGEF2, CLDN1, AGO2, ANXA6, FGB |
568 protein signatures that were found enriched in ozone-exposed mice versus air-exposed mice were interrogated for their respective gene signature upregulation in three different tissues, i.e., airway, parenchyma, and alveolar macrophages.